seed
Stage
2014
Founded
1
Investors
About
Phenex is a spin-off from the University of Tübingen developing innovative small molecule therapies for metabolic diseases like diabetes and non-alcoholic steatohepatitis (NASH). Its lead candidate, Px-800, is in preclinical development.
Explore Phenex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.